One last thought before I crash out for the night (morning).....

Off the top of my head I can think of a couple companies that uplisted from the OTC to the Nasdaq....both were listed on the Toronto Venture.  One was Vuzix and the other was Stellar Biotech.

I don't think either of those companies had strong balance sheets when they uplisted...although both had some revenue, just not much.  In the case of Vuzix they did a 1:75 consolidation and secured a $25 million investment/partnership deal with Intel.....In looking over Stellar it looks like they only had maybe a little over $10 million in cash and equivilents when they uplisted.

Point being this....I don't know how much money Resverlogix would need to show on its balance sheet in order to qualify to list on the Nasdaq...but I'm assuming $10 million or so in cash combined with $14 or so million in debt.....that this wouldn't be enough.  At the same time I don't think they'd need to get up into the $50 to $80 million range eitehr.  

Anyone have any thoughts as to what kind of cash balance they might need?  I'll read it tomorrow around noon probably.